Rothschild Investment LLC Keros Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 40 shares of KROS stock, worth $2,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 15
166.67%
Holding current value
$2,686
Previous $686,000
238.63%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KROS
# of Institutions
158Shares Held
27.5MCall Options Held
28.7KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$118 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$107 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$102 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$85.2 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.73B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...